Molgradex

molgramostim · Savara Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Molgradex, covering 2024-07-03 to 2026-02-19. Get the full timeline:

Most recent: Clinical Trial Update: Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP). [Phase 3]